✦ LIBER ✦

Treatment of chronic atrial fibrillation with warfarin or aspirin: A cost-effectiveness and cost-utility analysis.

✍ Scribed by Zamke, K.B.; Levine, M.A.H.; O'Brien, B.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cost-effectiveness of Apixaban versus Wa

✍ Lanitis, Tereza; Kongnakorn, Thitima; Jacobson, Lena; De Geer, Anna 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 487 KB

Cost–Effectiveness of Clopidogrel Plus A

✍ Craig I. Coleman; Andrew D. Straznitskas; Diana M. Sobieraj; Jeffrey Kluger; Moi 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 615 KB

PCV57 Cost-Effectiveness of Rivaroxaban

✍ A.K. Kapur; I. Chatzitheofilou; L.K. Schang 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB

Cost-effectiveness of apixaban vs warfar

✍ Kamel, H.; Easton, J. D.; Johnston, S. C.; Kim, A. S. 📂 Article 📅 2012 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 578 KB

Cost-Effectiveness Analysis of Apixaban

✍ Galindo-Suárez, R.M.; Davila-Veites, A.; Olguin-Sánchez, J.F.; Haddad, A.; del A 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB

PCV73 Prevention of Stroke in Patients W

✍ M. Psenkova; M. Lukac; S. Mackovicova; M. Stachova; J. Bielik; G.A. Pietsch; Y. 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB